Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an initial public offering (IPO) on the week of April 7th, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on the week of April 7th, IPO Scoop reports.

Discover how particle drift analysis using flux tools improves oral drug absorption in pharmaceutical research.

“I See You’ve Called in Dead” follows a middle-aged depressive who rediscovers life’s joys, with a little help from his friends. Steve Oney’s engaging and deeply reported “On Air ...

Nerve health has become a critical concern for many individuals suffering from conditions such as neuropathy, sciatica, and ...

Is the AquaSculpt Scam real? Discover the truth about AquaSculpt, its effectiveness, and how to avoid fraud by ordering from ...

However, unlike Bristol-Myers Squibb, which announced the approval of Opdivo Qvantig, the subcutaneous formulation of Opdivo ... So, according to the FDA's Orange Book, it expires on February ...

With his first book since winning the Nobel Prize in literature in 2021, Burnah focuses on three young people — an ambitious college student returning home, his female friend looking for a way ...

Learn about real Aqua Sculpt reviews, Its formulation, benefits, and user experiences in our thorough review. Read ...

It is a strategic opportunity for China and other BRICS countries to fill the financial gaps and shape the future of global health. Published 07 Feb, 2025 07:11am ...

Apple's iPad Air is getting rave reviews, but even the most advanced iPad doesn't include a case that fits your stylistic and functional needs. We've scoured the best options available to bring ...